PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Emport, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

G12 Antibody Identifies Gluten in Some Oat Varieties - A recent study discovered that different varieties of oat contain different levels of gluten. Researchers used the G12 antibody to identify three distinct categories of oat, proving that only some oats are safe for those on a gluten-free diet
G12 Antibody Identifies Gluten in Some Oat Varieties

 

NewswireToday - /newswire/ - Pittsburgh, PA, United States, 2011/06/06 - A recent study discovered that different varieties of oat contain different levels of gluten. Researchers used the G12 antibody to identify three distinct categories of oat, proving that only some oats are safe for those on a gluten-free diet.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Oats have been a source of controversy in the gluten-free world for years, as people debate whether or not they are gluten-free. A recent study has the answer: maybe.

The study, published in GUT - An International Journal of Gastroenterology and Hepatology, examined several different oat varieties. The oats were analyzed via both an ELISA test and a western blot, using the G12 antibody. This antibody, developed by Biomedal, the University of Seville and Stanford University, specifically reacts to the 33-mer peptide, the fraction of gluten toxic to those with celiac disease.

Results indicated that the oats could be split into three distinct groups: those with no detectable reactivity / no detectable gluten, those with a slight reactivity, and those with high reactivity.

This discovery is notable for two reasons: first, it shows that cross-contamination where oats are grown or processed is not the only reason why someone with celiac disease might react negatively. Secondly, the success of the G12 antibody opens a pathway to identifying truly gluten-free varieties of oat, which can be safely ingested by all celiacs. Currently there is no international consensus on whether or not oats should be part of a gluten-free diet, and as many as 1 in 10 American celiacs currently have negative reactions even oats that are labeled gluten-free.

“Oats are probably the most confusing food out there for many celiacs,” said Emily Kaufman, president of Emport LLC. “A lot of the information available online is misleading, outdated, or just plain wrong, so this research is a huge clarification for the gluten-free community.”

Whereas wheat contains a protein called gliadin, oats contain avenin. The concentration of gluten in avenin is estimated to be 40 to 400 times weaker than that in gliadin, which partially explains why many celiacs can tolerate oats.

Research indicates that most — but not all — people with celiac disease can ingest up to 50mg of gluten a day without adverse effects.

Because it uses the same G12 antibodies as the study, GlutenTox Home can provide celiacs with a means to incorporate or exclude certain oat varieties from their diets. In fact, the study results were replicated when researchers at Biomedal used GlutenTox Home to test the same oat varieties. The test is also able to detect gluten from wheat, barley and rye, and works with foods, drinks, medications and cosmetics.

Currently distributed in Spain and other parts of Europe by Biomedal Diagnostics, GlutenTox Home is now available in the United States via Emport, LLC. In addition to selling the kit online, Emport, LLC is working with retailers to place GlutenTox Home on store shelves nationwide. More information about GlutenTox Home is available at glutentox.com/.

About Emport, LLC

Emily Kaufman began Emport, LLC (emportllc.com) in 2011 as a way to further help fellow celiacs stay safe, healthy, and well-fed. Emport is focused on making GlutenTox Home available in the US, and dedicated to raising awareness of celiac disease.

About Biomedal Diagnostics

Biomedal S.L. (biomedal.com) is a biotechnology company whose mission is to develop and commercialize new technologies, services and products for research, bioindustry and diagnostics. Biomedal Diagnostics offers a large variety of products and services related to human health. It already holds a position in the market of products for analysis related to immunological diseases, and rapid tools for food safety analysis.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Emport, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


G12 Antibody Identifies Gluten in Some Oat Varieties

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Emily Kaufman - EmportLLC.com 
412-447-1888 emilyk[.]emportllc.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Emport, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Emport, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)